| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
|
|
|
|
|||||||||||||
|
|
|||||||||||||||
ASTHMA |
1 Regional Respiratory Centre, Belfast City Hospital, Belfast, UK
2 Department of Medicine, Queens University, Belfast, UK
3 Department of Mental Health, Queens University, Belfast
4 Department of Epidemiology and Statistics, Queens University, Belfast
Correspondence to:
Correspondence to:
Dr L G Heaney, Regional Respiratory Centre, Level 8, Belfast City Hospital, Lisburn Road, Belfast BT9 7AB, UK;
Liam.Heaney{at}bch.n-i.nhs.uk
Background: It has been suggested that asthmatic subjects with persisting symptoms despite adequate maintenance therapy should be systematically evaluated to identify factors contributing to poor control. The aims of this study were to examine the prevalence of these factors in a cohort of sequentially referred poorly controlled asthmatics, and to determine if any factor or combination of factors predicted true therapy resistant asthma (TRA).
Methods: Patients were evaluated using a systematic evaluation protocol including induced sputum analysis, psychiatric assessment, ear, nose and throat examination, pulmonary function testing, high resolution CT scan of the thorax, and 24 hour dual probe ambulatory oesophageal pH monitoring; any identified provoking factor was treated. Asthma was managed according to BTS guidelines.
Results: Of 73 subjects who completed the assessment, 39 responded to intervention and 34 had TRA. Subjects with TRA had a greater period of instability, a higher dose of inhaled steroids at referral, more rescue steroid use, and a lower best percentage forced expiratory volume in 1 second (FEV1%). Oesophageal reflux, upper airway disease, and psychiatric morbidity were common (57%, 95%, 49%, respectively) but were not more prevalent in either group. Using multivariate logistic regression analysis, inhaled steroid dose >2000 µg BDP, previous assessment by a respiratory specialist, and initial FEV1% of <70% at referral predicted a final diagnosis of TRA.
Conclusions: In poorly controlled asthmatics there is a high prevalence of co-morbidity, identified by detailed systematic assessment, but no difference in prevalence between those who respond to intervention and those with TRA. Targeted treatment of identified co-morbidities has minimal impact on asthma related quality of life in those with therapy resistant disease.
Keywords: difficult asthma; clinical evaluation; asthma
Relevant Article
Thorax 2003 58: 555.
This article has been cited by other articles:
|
|
 |
|
  S. Holgate, H. Bisgaard, L. Bjermer, T. Haahtela, J. Haughney, R. Horne, A. McIvor, S. Palkonen, D. B. Price, M. Thomas, et al. The Brussels Declaration: the need for change in asthma management Eur. Respir. J., December 1, 2008; 32(6): 1433 - 1442. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R C Reddy Severe asthma: approach and management Postgrad. Med. J., March 1, 2008; 84(989): 115 - 120. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Shannon, P. Ernst, Y. Yamauchi, R. Olivenstein, C. Lemiere, S. Foley, L. Cicora, M. Ludwig, Q. Hamid, and J. G. Martin Differences in Airway Cytokine Profile in Severe Asthma Compared to Moderate Asthma Chest, February 1, 2008; 133(2): 420 - 426. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B D Havemann, C A Henderson, and H B El-Serag The association between gastro-oesophageal reflux disease and asthma: a systematic review Gut, December 1, 2007; 56(12): 1654 - 1664. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. R. Partridge Examining the unmet need in adults with severe asthma Eur. Respir. Rev., September 1, 2007; 16(104): 67 - 72. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. J. Roberts, D. S. Robinson, and M. R. Partridge How is difficult asthma managed? Eur. Respir. J., November 1, 2006; 28(5): 968 - 973. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Butler and L. G. Heaney Risk factors of frequent exacerbations in difficult-to-treat asthma. Eur. Respir. J., June 1, 2006; 27(6): 1324 - 1325. [Full Text] [PDF]
|
|
|
|
|
|
D. W. Denning, B. R. O'Driscoll, C. M. Hogaboam, P. Bowyer, and R. M. Niven The link between fungi and severe asthma: a summary of the evidence. Eur. Respir. J., March 1, 2006; 27(3): 615 - 626. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. E. Strek Difficult asthma. Proceedings of the ATS, January 1, 2006; 3(1): 116 - 123. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. ten Brinke, P. J. Sterk, A. A. M. Masclee, P. Spinhoven, J. T. Schmidt, A. H. Zwinderman, K. F. Rabe, and E. H. Bel Risk factors of frequent exacerbations in difficult-to-treat asthma Eur. Respir. J., November 1, 2005; 26(5): 812 - 818. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Martinez-Garcia, M. Perpina-Tordera, P. Roman-Sanchez, and J. J. Soler-Cataluna Quality-of-Life Determinants in Patients With Clinically Stable Bronchiectasis Chest, August 1, 2005; 128(2): 739 - 745. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Leggett, B. T. Johnston, M. Mills, J. Gamble, and L. G. Heaney Prevalence of Gastroesophageal Reflux in Difficult Asthma: Relationship to Asthma Outcome Chest, April 1, 2005; 127(4): 1227 - 1231. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Gaga Fixed obstruction in severe asthma: not just a matter of time Eur. Respir. J., July 1, 2004; 24(1): 8 - 10. [Full Text] [PDF]
|
|
|
|
 |
|
 S.T. Holgate Lessons learnt from the epidemic of asthma QJM, May 1, 2004; 97(5): 247 - 257. [Full Text] [PDF]
|
|
|
|
 |
|
 C F Everett, J A Kastelik, S A Mulrennan, A H Morice, L Heaney, and B Johnston Predictors of therapy resistant asthma * Authors' reply Thorax, March 1, 2004; 59(3): 270 - 271. [Full Text] [PDF]
|
|
|
|
|
|
B D W Harrison Difficult asthma Thorax, July 1, 2003; 58(7): 555 - 556. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
